ADHERENCE TO TRIPLE THERAPY IN HCV

被引：0
|
作者：
Morisco, F. [1 ]
Di Costanzo, G. G. [2 ]
Camera, S. [1 ]
Guarino, M. [1 ]
Clery, E. [1 ]
Ferraiuoli, C. [1 ]
Granata, R. [1 ]
Loperto, I. [1 ]
Cossiga, V. [1 ]
Lampasi, F. [2 ]
Tartaglione, M. T. [2 ]
Caporaso, N. [1 ]
机构：
[1] Univ Naples Federico II, Gastroenterol Units, Dept Clin Med & Surg, Naples, Italy
[2] Cardarelli Hosp, Liver Unit, Naples, Italy
来源：
DIGESTIVE AND LIVER DISEASE | 2014年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P.17.10
引用
收藏
页码：S123 / S124
页数：2
相关论文
共 50 条
  • [21] Dual versus triple therapy in treatment of hepatitis C virus (HCV)
    Bishai, Nevine
    El Nabawy, Walid
    El Fiki, Mohamed
    Ibrahim, Mohamed
    El Garem, Nouman
    IRISH JOURNAL OF MEDICAL SCIENCE, 2023, 192 (03) : 1129 - 1135
  • [22] The role of triple therapy in HCV genotype 1-experienced patients
    Fried, Michael W.
    LIVER INTERNATIONAL, 2011, 31 : 58 - 61
  • [23] Compact triple nucleoside therapy can impact adherence in the prison setting
    Rosenzweig, JC
    Fischl, M
    Kirkland, L
    Tashima, K
    Paar, D
    Gensler, T
    Capuano, G
    Hernandez, J
    AIDS, 2000, 14 : S50 - S50
  • [24] Detection of low HCV viraemia by repeated HCV RNA testing predicts treatment failure to triple therapy with telaprevir
    Maasoumy, B.
    Cobb, B.
    Bremer, B.
    Luk, K.
    Halfon, P.
    Aslam, S.
    Manns, M. P.
    Cornberg, M.
    Wedemeyer, H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (01) : 85 - 92
  • [25] "Fighting an uphill battle": experience with the HCV triple therapy: a qualitative thematic analysis
    Rasi, Manuela
    Kuenzler-Heule, Patrizia
    Schmid, Patrick
    Semela, David
    Bruggmann, Philip
    Fehr, Jan
    Saxer, Susi
    Nicca, Dunja
    BMC INFECTIOUS DISEASES, 2014, 14
  • [26] Cost Effectiveness of HCV triple therapy with protease inhibitors; the true cost of SVR
    Sethi, Nidhi
    Vong, Annie
    Firdoos, Saima
    Rourke, Meredith
    Afdhal, Nezam H.
    HEPATOLOGY, 2013, 58 : 1094A - 1094A
  • [27] “Fighting an uphill battle”: experience with the HCV triple therapy: a qualitative thematic analysis
    Manuela Rasi
    Patrizia Künzler-Heule
    Patrick Schmid
    David Semela
    Philip Bruggmann
    Jan Fehr
    Susi Saxer
    Dunja Nicca
    BMC Infectious Diseases, 14
  • [28] Triglyceride levels predict rapid virological response to triple therapy with telaprevir in HCV
    Jaeckel, Elmar
    Mauss, Stefan
    Moog, Gero
    Heyne, Renate
    Teuber, Gerlinde
    Doss, Margareta Frank
    Hueppe, Dietrich
    Witthoeft, Thomas
    Herold, Christoph
    Weber, Bernd
    Buggisch, Peter
    Stoll, Sabine
    Manns, Michael P.
    HEPATOLOGY, 2012, 56 : 1036A - 1036A
  • [29] Sustained Virologic Response with Triple Therapy in a Hemodialysis Patient with Chronic HCV Infection
    Kaygusuz, Sedat
    Gul, Serdar
    Gulhan, Muhammet
    MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS, 2014, 3
  • [30] Prediction of relapse after interferon therapy in HCV infection by use of triple assay
    El-Awady, M
    JOURNAL OF HEPATOLOGY, 2002, 36 : 222 - 222
12345